- Home
- REG vs NBIX Comparison
REG vs NBIX Comparison
Compare REG & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REG
- NBIX
- Stock Information
- Founded
- REG 1963
- NBIX 1992
- Country
- REG United States
- NBIX United States
- Employees
- REG N/A
- NBIX N/A
- Industry
- REG Real Estate Investment Trusts
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- REG Real Estate
- NBIX Health Care
- Exchange
- REG Nasdaq
- NBIX Nasdaq
- Market Cap
- REG 13.4B
- NBIX 13.7B
- IPO Year
- REG 1993
- NBIX 1996
- Fundamental
- Price
- REG $71.22
- NBIX $143.26
- Analyst Decision
- REG Buy
- NBIX Buy
- Analyst Count
- REG 13
- NBIX 22
- Target Price
- REG $77.54
- NBIX $164.81
- AVG Volume (30 Days)
- REG 1.1M
- NBIX 1.0M
- Earning Date
- REG 02-06-2025
- NBIX 02-05-2025
- Dividend Yield
- REG 3.96%
- NBIX N/A
- EPS Growth
- REG 0.21
- NBIX 97.40
- EPS
- REG 2.12
- NBIX 3.73
- Revenue
- REG $1,489,813,000.00
- NBIX $2,242,800,000.00
- Revenue This Year
- REG N/A
- NBIX $27.07
- Revenue Next Year
- REG $3.78
- NBIX $17.14
- P/E Ratio
- REG $33.53
- NBIX $38.43
- Revenue Growth
- REG 13.47
- NBIX 25.72
- 52 Week Low
- REG $56.51
- NBIX $110.95
- 52 Week High
- REG $76.53
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- REG 44.00
- NBIX 66.20
- Support Level
- REG $68.44
- NBIX $138.66
- Resistance Level
- REG $72.24
- NBIX $144.24
- Average True Range (ATR)
- REG 1.35
- NBIX 3.23
- MACD
- REG -0.07
- NBIX 0.07
- Stochastic Oscillator
- REG 43.17
- NBIX 82.29
About REG Regency Centers Corporation
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.